{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:53:52Z","timestamp":1787003632697,"version":"build-2736575974"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,5,16]],"date-time":"2023-05-16T00:00:00Z","timestamp":1684195200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,16]],"date-time":"2023-05-16T00:00:00Z","timestamp":1684195200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004844","name":"National Cheng Kung University Hospital","doi-asserted-by":"publisher","award":["NCKUH-11106011"],"award-info":[{"award-number":["NCKUH-11106011"]}],"id":[{"id":"10.13039\/501100004844","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Alveolar macrophages (AMs) are the drivers of pulmonary cytokine storm in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. This study aimed to investigate clinical\u2013regulatory factors for the entrance protein of SARS-CoV-2, angiotensin\u2013converting enzyme 2 (ACE2) in AMs. Human AMs were collected from 56 patients using bronchoalveolar lavage. ACE2 expression in AMs was positively correlated with smoking pack-year (Spearman\u2019s r\u2009=\u20090.347, P\u2009=\u20090.038). In multivariate analysis, current smoking was associated with increased ACE2 in AMs (\u03b2-coefficient: 0.791, 95% CI 0.019\u20131.562, P\u2009=\u20090.045). In vitro study, ex-vivo human AMs with higher ACE2 were more susceptible to SARS-CoV-2 pseudovirus (CoV-2 PsV). Treating human AMs using cigarette smoking extract (CSE) increases the ACE2 and susceptibility to CoV-2 PsV. CSE did not significantly increase the ACE2 in AMs of reactive oxygen species (ROS) deficient Cybb\n                    <jats:sup>\u2013\/\u2013<\/jats:sup>\n                    mice; however, exogenous ROS increased the ACE2 in Cybb\n                    <jats:sup>\u2013\/\u2013<\/jats:sup>\n                    AMs. N-acetylcysteine (NAC) decreases ACE2 by suppressing intracellular ROS in human AMs. In conclusion, cigarette smoking increases the susceptibility to SARS-CoV-2 by increasing ROS\u2013induced ACE2 expression of AMs. Further investigation into the preventive effect of NAC on the pulmonary complications of COVID-19 is required.\n                  <\/jats:p>","DOI":"10.1038\/s41598-023-34785-6","type":"journal-article","created":{"date-parts":[[2023,5,16]],"date-time":"2023-05-16T06:01:50Z","timestamp":1684216910000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Cigarette smoke increases susceptibility of alveolar macrophages to SARS-CoV-2 infection through inducing reactive oxygen species-upregulated angiotensin-converting enzyme 2 expression"],"prefix":"10.1038","volume":"13","author":[{"given":"Chin-Wei","family":"Kuo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-Lan","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tang-Hsiu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chien-Chung","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chian-Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeng-Shiuan","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Min","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tzu-Yi","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Chang","family":"Shieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,16]]},"reference":[{"key":"34785_CR1","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1056\/NEJMoa2001017","volume":"382","author":"N Zhu","year":"2020","unstructured":"Zhu, N. et al. A novel coronavirus from patients with pneumonia in China, 2019. N. Engl. J. Med. 382, 727\u2013733. https:\/\/doi.org\/10.1056\/NEJMoa2001017 (2020).","journal-title":"N. Engl. J. Med."},{"key":"34785_CR2","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/s2213-2600(20)30459-8","volume":"9","author":"M Botta","year":"2021","unstructured":"Botta, M. et al. Ventilation management and clinical outcomes in invasively ventilated patients with COVID-19 (PRoVENT-COVID): A national, multicentre, observational cohort study. Lancet Respir. Med. 9, 139\u2013148. https:\/\/doi.org\/10.1016\/s2213-2600(20)30459-8 (2021).","journal-title":"Lancet Respir. Med."},{"key":"34785_CR3","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1056\/NEJMc2206576","volume":"387","author":"NP Hachmann","year":"2022","unstructured":"Hachmann, N. P. et al. Neutralization escape by SARS-CoV-2 omicron subvariants BA.2.12.1, BA.4, and BA.5. N. Engl. J. Med. 387, 86\u201388. https:\/\/doi.org\/10.1056\/NEJMc2206576 (2022).","journal-title":"N. Engl. J. Med."},{"key":"34785_CR4","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/s41591-021-01643-9","volume":"28","author":"FL van de Veerdonk","year":"2022","unstructured":"van de Veerdonk, F. L. et al. A guide to immunotherapy for COVID-19. Nat. Med. 28, 39\u201350. https:\/\/doi.org\/10.1038\/s41591-021-01643-9 (2022).","journal-title":"Nat. Med."},{"key":"34785_CR5","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1161\/01.res.87.5.e1","volume":"87","author":"M Donoghue","year":"2000","unstructured":"Donoghue, M. et al. A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1\u20139. Circ. Res. 87, E1-9. https:\/\/doi.org\/10.1161\/01.res.87.5.e1 (2000).","journal-title":"Circ. Res."},{"key":"34785_CR6","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","volume":"181","author":"M Hoffmann","year":"2020","unstructured":"Hoffmann, M. et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181, 271-280.e278. https:\/\/doi.org\/10.1016\/j.cell.2020.02.052 (2020).","journal-title":"Cell"},{"key":"34785_CR7","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1126\/science.abn7760","volume":"375","author":"D Mannar","year":"2022","unstructured":"Mannar, D. et al. SARS-CoV-2 omicron variant: Antibody evasion and cryo-EM structure of spike protein-ACE2 complex. Science 375, 760\u2013764. https:\/\/doi.org\/10.1126\/science.abn7760 (2022).","journal-title":"Science"},{"key":"34785_CR8","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1038\/s41591-020-01227-z","volume":"27","author":"C Muus","year":"2021","unstructured":"Muus, C. et al. Single-cell meta-analysis of SARS-CoV-2 entry genes across tissues and demographics. Nat. Med. 27, 546\u2013559. https:\/\/doi.org\/10.1038\/s41591-020-01227-z (2021).","journal-title":"Nat. Med."},{"key":"34785_CR9","doi-asserted-by":"publisher","first-page":"360","DOI":"10.14336\/ad.2021.0805","volume":"13","author":"M Zheng","year":"2022","unstructured":"Zheng, M. ACE2 and COVID-19 susceptibility and severity. Aging Dis 13, 360\u2013372. https:\/\/doi.org\/10.14336\/ad.2021.0805 (2022).","journal-title":"Aging Dis"},{"key":"34785_CR10","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.2147\/jir.S300747","volume":"14","author":"W Bao","year":"2021","unstructured":"Bao, W. et al. Factors associated with the expression of ACE2 in human lung tissue: Pathological evidence from patients with normal FEV(1) and FEV(1)\/FVC. J. Inflamm. Res. 14, 1677\u20131687. https:\/\/doi.org\/10.2147\/jir.S300747 (2021).","journal-title":"J. Inflamm. Res."},{"key":"34785_CR11","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1164\/rccm.202003-0693LE","volume":"201","author":"G Cai","year":"2020","unstructured":"Cai, G., Boss\u00e9, Y., Xiao, F., Kheradmand, F. & Amos, C. I. Tobacco smoking increases the lung gene expression of ACE2, the receptor of SARS-CoV-2. Am. J. Respir. Crit. Care Med. 201, 1557\u20131559. https:\/\/doi.org\/10.1164\/rccm.202003-0693LE (2020).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"34785_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/v12101174","author":"Y Liu","year":"2020","unstructured":"Liu, Y., Qu, H. Q., Qu, J., Tian, L. & Hakonarson, H. Expression pattern of the SARS-CoV-2 entry genes ACE2 and TMPRSS2 in the respiratory tract. Viruses https:\/\/doi.org\/10.3390\/v12101174 (2020).","journal-title":"Viruses"},{"key":"34785_CR13","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1038\/s41591-020-0868-6","volume":"26","author":"W Sungnak","year":"2020","unstructured":"Sungnak, W. et al. SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes. Nat. Med. 26, 681\u2013687. https:\/\/doi.org\/10.1038\/s41591-020-0868-6 (2020).","journal-title":"Nat. Med."},{"key":"34785_CR14","doi-asserted-by":"publisher","first-page":"e0247060","DOI":"10.1371\/journal.pone.0247060","volume":"16","author":"SA Baker","year":"2021","unstructured":"Baker, S. A., Kwok, S., Berry, G. J. & Montine, T. J. Angiotensin-converting enzyme 2 (ACE2) expression increases with age in patients requiring mechanical ventilation. PLoS One 16, e0247060. https:\/\/doi.org\/10.1371\/journal.pone.0247060 (2021).","journal-title":"PLoS One"},{"key":"34785_CR15","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1002\/cyto.a.24285","volume":"103","author":"X Song","year":"2023","unstructured":"Song, X. et al. Little to no expression of angiotensin-converting enzyme-2 on most human peripheral blood immune cells but highly expressed on tissue macrophages. Cytom. A 103, 136\u2013145. https:\/\/doi.org\/10.1002\/cyto.a.24285 (2023).","journal-title":"Cytom. A"},{"key":"34785_CR16","doi-asserted-by":"publisher","first-page":"4441","DOI":"10.1128\/jvi.02541-07","volume":"82","author":"PK Pribul","year":"2008","unstructured":"Pribul, P. K. et al. Alveolar macrophages are a major determinant of early responses to viral lung infection but do not influence subsequent disease development. J. Virol. 82, 4441\u20134448. https:\/\/doi.org\/10.1128\/jvi.02541-07 (2008).","journal-title":"J. Virol."},{"key":"34785_CR17","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1056\/NEJMc1711824","volume":"377","author":"BT Thompson","year":"2017","unstructured":"Thompson, B. T., Chambers, R. C. & Liu, K. D. Acute respiratory distress syndrome. N. Engl. J. Med. 377, 1904\u20131905. https:\/\/doi.org\/10.1056\/NEJMc1711824 (2017).","journal-title":"N. Engl. J. Med."},{"key":"34785_CR18","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1164\/rccm.201807-1381OC","volume":"200","author":"ED Morrell","year":"2019","unstructured":"Morrell, E. D. et al. Alveolar macrophage transcriptional programs are associated with outcomes in acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 200, 732\u2013741. https:\/\/doi.org\/10.1164\/rccm.201807-1381OC (2019).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"34785_CR19","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41421-021-00258-1","volume":"7","author":"J Lv","year":"2021","unstructured":"Lv, J. et al. Distinct uptake, amplification, and release of SARS-CoV-2 by M1 and M2 alveolar macrophages. Cell Discov. 7, 24. https:\/\/doi.org\/10.1038\/s41421-021-00258-1 (2021).","journal-title":"Cell Discov."},{"key":"34785_CR20","doi-asserted-by":"publisher","first-page":"102833","DOI":"10.1016\/j.ebiom.2020.102833","volume":"57","author":"C Wang","year":"2020","unstructured":"Wang, C. et al. Alveolar macrophage dysfunction and cytokine storm in the pathogenesis of two severe COVID-19 patients. EBioMedicine 57, 102833. https:\/\/doi.org\/10.1016\/j.ebiom.2020.102833 (2020).","journal-title":"EBioMedicine"},{"key":"34785_CR21","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1038\/s41423-021-00665-0","volume":"18","author":"J Zhang","year":"2021","unstructured":"Zhang, J. et al. Pyroptotic macrophages stimulate the SARS-CoV-2-associated cytokine storm. Cell. Mol. Immunol. 18, 1305\u20131307. https:\/\/doi.org\/10.1038\/s41423-021-00665-0 (2021).","journal-title":"Cell. Mol. Immunol."},{"key":"34785_CR22","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1165\/rcmb.2015-0146OC","volume":"54","author":"YR Yu","year":"2016","unstructured":"Yu, Y. R. et al. Flow cytometric analysis of myeloid cells in human blood, bronchoalveolar lavage, and lung tissues. Am. J. Respir. Cell Mol. Biol. 54, 13\u201324. https:\/\/doi.org\/10.1165\/rcmb.2015-0146OC (2016).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"34785_CR23","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1007\/s11626-019-00426-4","volume":"56","author":"H Feng","year":"2020","unstructured":"Feng, H. et al. Effect of CSE on M1\/M2 polarization in alveolar and peritoneal macrophages at different concentrations and exposure in vitro. In Vitro Cell. Dev. Biol. Anim. 56, 154\u2013164. https:\/\/doi.org\/10.1007\/s11626-019-00426-4 (2020).","journal-title":"In Vitro Cell. Dev. Biol. Anim."},{"key":"34785_CR24","doi-asserted-by":"publisher","first-page":"368504221074574","DOI":"10.1177\/00368504221074574","volume":"105","author":"JL Izquierdo","year":"2022","unstructured":"Izquierdo, J. L. et al. Use of N-Acetylcysteine at high doses as an oral treatment for patients hospitalized with COVID-19. Sci. Prog. 105, 368504221074574. https:\/\/doi.org\/10.1177\/00368504221074574 (2022).","journal-title":"Sci. Prog."},{"key":"34785_CR25","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00542-2021","author":"P Faverio","year":"2022","unstructured":"Faverio, P. et al. Impact of N-acetyl-l-cysteine on SARS-CoV-2 pneumonia and its sequelae: Results from a large cohort study. ERJ Open Res. https:\/\/doi.org\/10.1183\/23120541.00542-2021 (2022).","journal-title":"ERJ Open Res."},{"key":"34785_CR26","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.cytogfr.2020.06.001","volume":"54","author":"VJ Costela-Ruiz","year":"2020","unstructured":"Costela-Ruiz, V. J., Illescas-Montes, R., Puerta-Puerta, J. M., Ruiz, C. & Melguizo-Rodr\u00edguez, L. SARS-CoV-2 infection: The role of cytokines in COVID-19 disease. Cytokine Growth Factor Rev. 54, 62\u201375. https:\/\/doi.org\/10.1016\/j.cytogfr.2020.06.001 (2020).","journal-title":"Cytokine Growth Factor Rev."},{"key":"34785_CR27","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/s0140-6736(20)30628-0","volume":"395","author":"P Mehta","year":"2020","unstructured":"Mehta, P. et al. COVID-19: Consider cytokine storm syndromes and immunosuppression. Lancet 395, 1033\u20131034. https:\/\/doi.org\/10.1016\/s0140-6736(20)30628-0 (2020).","journal-title":"Lancet"},{"key":"34785_CR28","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1002\/art.41285","volume":"72","author":"LA Henderson","year":"2020","unstructured":"Henderson, L. A. et al. On the alert for cytokine storm: Immunopathology in COVID-19. Arthritis Rheumatol. 72, 1059\u20131063. https:\/\/doi.org\/10.1002\/art.41285 (2020).","journal-title":"Arthritis Rheumatol."},{"key":"34785_CR29","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1056\/NEJMoa2030340","volume":"384","author":"C Salama","year":"2021","unstructured":"Salama, C. et al. Tocilizumab in patients hospitalized with Covid-19 pneumonia. N. Engl. J. Med. 384, 20\u201330. https:\/\/doi.org\/10.1056\/NEJMoa2030340 (2021).","journal-title":"N. Engl. J. Med."},{"key":"34785_CR30","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/s0140-6736(22)01109-6","volume":"400","author":"O Abani","year":"2022","unstructured":"Abani, O. et al. Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): A randomised, controlled, open-label, platform trial and updated meta-analysis. Lancet 400, 359\u2013368. https:\/\/doi.org\/10.1016\/s0140-6736(22)01109-6 (2022).","journal-title":"Lancet"},{"key":"34785_CR31","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/s0140-6736(20)30566-3","volume":"395","author":"F Zhou","year":"2020","unstructured":"Zhou, F. et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study. Lancet 395, 1054\u20131062. https:\/\/doi.org\/10.1016\/s0140-6736(20)30566-3 (2020).","journal-title":"Lancet"},{"key":"34785_CR32","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/s2213-2600(20)30079-5","volume":"8","author":"X Yang","year":"2020","unstructured":"Yang, X. et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: A single-centered, retrospective, observational study. Lancet Respir. Med. 8, 475\u2013481. https:\/\/doi.org\/10.1016\/s2213-2600(20)30079-5 (2020).","journal-title":"Lancet Respir. Med."},{"key":"34785_CR33","doi-asserted-by":"publisher","first-page":"e4208","DOI":"10.1093\/cid\/ciaa270","volume":"73","author":"P Mo","year":"2021","unstructured":"Mo, P. et al. Clinical characteristics of refractory coronavirus disease 2019 in Wuhan, China. Clin. Infect. Dis. 73, e4208\u2013e4213. https:\/\/doi.org\/10.1093\/cid\/ciaa270 (2021).","journal-title":"Clin. Infect. Dis."},{"key":"34785_CR34","doi-asserted-by":"publisher","first-page":"e111","DOI":"10.1136\/tobaccocontrol-2020-055933","volume":"30","author":"SE Jackson","year":"2021","unstructured":"Jackson, S. E., Brown, J., Shahab, L., Steptoe, A. & Fancourt, D. COVID-19, smoking and inequalities: A study of 53 002 adults in the UK. Tob. Control 30, e111\u2013e121. https:\/\/doi.org\/10.1136\/tobaccocontrol-2020-055933 (2021).","journal-title":"Tob. Control"},{"key":"34785_CR35","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1111\/add.15251","volume":"116","author":"H Tattan-Birch","year":"2021","unstructured":"Tattan-Birch, H. et al. COVID-19, smoking, vaping and quitting: A representative population survey in England. Addiction 116, 1186\u20131195. https:\/\/doi.org\/10.1111\/add.15251 (2021).","journal-title":"Addiction"},{"key":"34785_CR36","doi-asserted-by":"publisher","first-page":"60","DOI":"10.18332\/tid\/123845","volume":"18","author":"C Jiang","year":"2020","unstructured":"Jiang, C., Chen, Q. & Xie, M. Smoking increases the risk of infectious diseases: A narrative review. Tob. Induc. Dis. 18, 60. https:\/\/doi.org\/10.18332\/tid\/123845 (2020).","journal-title":"Tob. Induc. Dis."},{"key":"34785_CR37","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s12931-015-0291-6","volume":"16","author":"ME Givi","year":"2015","unstructured":"Givi, M. E., Folkerts, G., Wagenaar, G. T., Redegeld, F. A. & Mortaz, E. Cigarette smoke differentially modulates dendritic cell maturation and function in time. Respir. Res. 16, 131. https:\/\/doi.org\/10.1186\/s12931-015-0291-6 (2015).","journal-title":"Respir. Res."},{"key":"34785_CR38","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1183\/09031936.00061911","volume":"39","author":"J Garmendia","year":"2012","unstructured":"Garmendia, J., Morey, P. & Bengoechea, J. A. Impact of cigarette smoke exposure on host-bacterial pathogen interactions. Eur. Respir. J. 39, 467\u2013477. https:\/\/doi.org\/10.1183\/09031936.00061911 (2012).","journal-title":"Eur. Respir. J."},{"key":"34785_CR39","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1001\/archinte.164.20.2206","volume":"164","author":"L Arcavi","year":"2004","unstructured":"Arcavi, L. & Benowitz, N. L. Cigarette smoking and infection. Arch. Intern. Med. 164, 2206\u20132216. https:\/\/doi.org\/10.1001\/archinte.164.20.2206 (2004).","journal-title":"Arch. Intern. Med."},{"key":"34785_CR40","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.jinf.2019.08.014","volume":"79","author":"H Lawrence","year":"2019","unstructured":"Lawrence, H., Hunter, A., Murray, R., Lim, W. S. & McKeever, T. Cigarette smoking and the occurrence of influenza\u2014Systematic review. J. Infect. 79, 401\u2013406. https:\/\/doi.org\/10.1016\/j.jinf.2019.08.014 (2019).","journal-title":"J. Infect."},{"key":"34785_CR41","doi-asserted-by":"publisher","first-page":"613","DOI":"10.3390\/ijerph8020613","volume":"8","author":"R Talhout","year":"2011","unstructured":"Talhout, R. et al. Hazardous compounds in tobacco smoke. Int. J. Environ. Res. Public Health 8, 613\u2013628. https:\/\/doi.org\/10.3390\/ijerph8020613 (2011).","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"34785_CR42","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/nri2254","volume":"8","author":"PJ Barnes","year":"2008","unstructured":"Barnes, P. J. Immunology of asthma and chronic obstructive pulmonary disease. Nat. Rev. Immunol. 8, 183\u2013192. https:\/\/doi.org\/10.1038\/nri2254 (2008).","journal-title":"Nat. Rev. Immunol."},{"key":"34785_CR43","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00688-2020","author":"JM Leung","year":"2020","unstructured":"Leung, J. M. et al. ACE-2 expression in the small airway epithelia of smokers and COPD patients: Implications for COVID-19. Eur. Respir. J. https:\/\/doi.org\/10.1183\/13993003.00688-2020 (2020).","journal-title":"Eur. Respir. J."},{"key":"34785_CR44","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1002\/path.5555","volume":"253","author":"A Liu","year":"2021","unstructured":"Liu, A. et al. Overexpression of the SARS-CoV-2 receptor ACE2 is induced by cigarette smoke in bronchial and alveolar epithelia. J. Pathol. 253, 17\u201330. https:\/\/doi.org\/10.1002\/path.5555 (2021).","journal-title":"J. Pathol."},{"key":"34785_CR45","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.devcel.2020.05.012","volume":"53","author":"JC Smith","year":"2020","unstructured":"Smith, J. C. et al. Cigarette smoke exposure and inflammatory signaling increase the expression of the SARS-CoV-2 receptor ACE2 in the respiratory tract. Dev. Cell 53, 514-529.e513. https:\/\/doi.org\/10.1016\/j.devcel.2020.05.012 (2020).","journal-title":"Dev. Cell"},{"key":"34785_CR46","doi-asserted-by":"publisher","first-page":"L631","DOI":"10.1152\/ajplung.90415.2008","volume":"297","author":"R Zhang","year":"2009","unstructured":"Zhang, R. et al. Role of HIF-1alpha in the regulation ACE and ACE2 expression in hypoxic human pulmonary artery smooth muscle cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 297, L631-640. https:\/\/doi.org\/10.1152\/ajplung.90415.2008 (2009).","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"34785_CR47","doi-asserted-by":"publisher","first-page":"e736","DOI":"10.1093\/cid\/ciaa1443","volume":"72","author":"JCG de Alencar","year":"2021","unstructured":"de Alencar, J. C. G. et al. Double-blind, randomized, placebo-controlled trial with N-acetylcysteine for treatment of severe acute respiratory syndrome caused by coronavirus disease 2019 (COVID-19). Clin. Infect. Dis. 72, e736\u2013e741. https:\/\/doi.org\/10.1093\/cid\/ciaa1443 (2021).","journal-title":"Clin. Infect. Dis."},{"key":"34785_CR48","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1007\/s43440-021-00296-2","volume":"73","author":"A Taher","year":"2021","unstructured":"Taher, A. et al. A pilot study on intravenous N-Acetylcysteine treatment in patients with mild-to-moderate COVID19-associated acute respiratory distress syndrome. Pharmacol. Rep. 73, 1650\u20131659. https:\/\/doi.org\/10.1007\/s43440-021-00296-2 (2021).","journal-title":"Pharmacol. Rep."},{"key":"34785_CR49","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1164\/rccm.202001-0179LE","volume":"202","author":"Y Zhao","year":"2020","unstructured":"Zhao, Y. et al. Single-cell rna expression profiling of ACE2, the receptor of SARS-CoV-2. Am. J. Respir. Crit. Care Med. 202, 756\u2013759. https:\/\/doi.org\/10.1164\/rccm.202001-0179LE (2020).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"34785_CR50","doi-asserted-by":"publisher","first-page":"16629","DOI":"10.1038\/s41598-021-96109-w","volume":"11","author":"K Tanimoto","year":"2021","unstructured":"Tanimoto, K. et al. Inhibiting SARS-CoV-2 infection in vitro by suppressing its receptor, angiotensin-converting enzyme 2, via aryl-hydrocarbon receptor signal. Sci. Rep. 11, 16629. https:\/\/doi.org\/10.1038\/s41598-021-96109-w (2021).","journal-title":"Sci. Rep."},{"key":"34785_CR51","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s12929-021-00729-3","volume":"28","author":"SH Tseng","year":"2021","unstructured":"Tseng, S. H. et al. A novel pseudovirus-based mouse model of SARS-CoV-2 infection to test COVID-19 interventions. J. Biomed. Sci. 28, 34. https:\/\/doi.org\/10.1186\/s12929-021-00729-3 (2021).","journal-title":"J. Biomed. Sci."},{"key":"34785_CR52","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms9081744","author":"R Kalkeri","year":"2021","unstructured":"Kalkeri, R. et al. SARS-CoV-2 spike pseudoviruses: A useful tool to study virus entry and address emerging neutralization escape phenotypes. Microorganisms https:\/\/doi.org\/10.3390\/microorganisms9081744 (2021).","journal-title":"Microorganisms"},{"key":"34785_CR53","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.68563","author":"S Khan","year":"2021","unstructured":"Khan, S. et al. SARS-CoV-2 spike protein induces inflammation via TLR2-dependent activation of the NF-\u03baB pathway. Elife https:\/\/doi.org\/10.7554\/eLife.68563 (2021).","journal-title":"Elife"},{"key":"34785_CR54","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/s41423-020-0400-4","volume":"17","author":"W Tai","year":"2020","unstructured":"Tai, W. et al. Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: Implication for development of RBD protein as a viral attachment inhibitor and vaccine. Cell. Mol. Immunol. 17, 613\u2013620. https:\/\/doi.org\/10.1038\/s41423-020-0400-4 (2020).","journal-title":"Cell. Mol. Immunol."},{"key":"34785_CR55","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1056\/NEJMoa033250","volume":"354","author":"CA Haiman","year":"2006","unstructured":"Haiman, C. A. et al. Ethnic and racial differences in the smoking-related risk of lung cancer. N. Engl. J. Med. 354, 333\u2013342. https:\/\/doi.org\/10.1056\/NEJMoa033250 (2006).","journal-title":"N. Engl. J. Med."},{"key":"34785_CR56","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1164\/rccm.201202-0320ST","volume":"185","author":"KC Meyer","year":"2012","unstructured":"Meyer, K. C. et al. An official American Thoracic Society clinical practice guideline: The clinical utility of bronchoalveolar lavage cellular analysis in interstitial lung disease. Am. J. Respir. Crit. Care Med. 185, 1004\u20131014. https:\/\/doi.org\/10.1164\/rccm.201202-0320ST (2012).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"34785_CR57","doi-asserted-by":"publisher","first-page":"3813","DOI":"10.1007\/s00018-013-1286-4","volume":"70","author":"J Pillay","year":"2013","unstructured":"Pillay, J., Tak, T., Kamp, V. M. & Koenderman, L. Immune suppression by neutrophils and granulocytic myeloid-derived suppressor cells: Similarities and differences. Cell. Mol. Life Sci. 70, 3813\u20133827. https:\/\/doi.org\/10.1007\/s00018-013-1286-4 (2013).","journal-title":"Cell. Mol. Life Sci."},{"key":"34785_CR58","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1002\/cyto.b.21515","volume":"94","author":"O Mizrahi","year":"2018","unstructured":"Mizrahi, O., Ish Shalom, E., Baniyash, M. & Klieger, Y. Quantitative flow cytometry: Concerns and recommendations in clinic and research. Cytom. B Clin. Cytom. 94, 211\u2013218. https:\/\/doi.org\/10.1002\/cyto.b.21515 (2018).","journal-title":"Cytom. B Clin. Cytom."},{"key":"34785_CR59","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1038\/ncomms2906","volume":"4","author":"BH Su","year":"2013","unstructured":"Su, B. H. et al. Prothymosin \u03b1 overexpression contributes to the development of pulmonary emphysema. Nat. Commun. 4, 1906. https:\/\/doi.org\/10.1038\/ncomms2906 (2013).","journal-title":"Nat. Commun."},{"key":"34785_CR60","doi-asserted-by":"publisher","first-page":"L796","DOI":"10.1152\/ajplung.00334.2015","volume":"310","author":"BD Singer","year":"2016","unstructured":"Singer, B. D. et al. Flow-cytometric method for simultaneous analysis of mouse lung epithelial, endothelial, and hematopoietic lineage cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 310, L796-801. https:\/\/doi.org\/10.1152\/ajplung.00334.2015 (2016).","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"34785_CR61","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1164\/rccm.201712-2570OC","volume":"198","author":"J Zhang","year":"2018","unstructured":"Zhang, J. et al. AMP-activated protein kinase phosphorylation of angiotensin-converting enzyme 2 in endothelium mitigates pulmonary hypertension. Am. J. Respir. Crit. Care Med. 198, 509\u2013520. https:\/\/doi.org\/10.1164\/rccm.201712-2570OC (2018).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"34785_CR62","doi-asserted-by":"publisher","DOI":"10.3791\/57287","author":"DK Nayak","year":"2018","unstructured":"Nayak, D. K., Mendez, O., Bowen, S. & Mohanakumar, T. Isolation and in vitro culture of murine and human alveolar macrophages. J. Vis. Exp. https:\/\/doi.org\/10.3791\/57287 (2018).","journal-title":"J. Vis. Exp."},{"key":"34785_CR63","doi-asserted-by":"publisher","DOI":"10.21769\/BioProtoc.3302","author":"CJ Busch","year":"2019","unstructured":"Busch, C. J., Favret, J., Geirsd\u00f3ttir, L., Molawi, K. & Sieweke, M. H. Isolation and long-term cultivation of mouse alveolar macrophages. Bio-Protocol https:\/\/doi.org\/10.21769\/BioProtoc.3302 (2019).","journal-title":"Bio-Protocol"},{"key":"34785_CR64","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.1161\/circulationaha.104.510461","volume":"111","author":"CM Ferrario","year":"2005","unstructured":"Ferrario, C. M. et al. Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2. Circulation 111, 2605\u20132610. https:\/\/doi.org\/10.1161\/circulationaha.104.510461 (2005).","journal-title":"Circulation"},{"key":"34785_CR65","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13168","author":"J Chen","year":"2020","unstructured":"Chen, J. et al. Individual variation of the SARS-CoV-2 receptor ACE2 gene expression and regulation. Aging Cell https:\/\/doi.org\/10.1111\/acel.13168 (2020).","journal-title":"Aging Cell"},{"key":"34785_CR66","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s12943-020-01209-2","volume":"19","author":"Q Kong","year":"2020","unstructured":"Kong, Q. et al. Analysis of the susceptibility of lung cancer patients to SARS-CoV-2 infection. Mol. Cancer 19, 80. https:\/\/doi.org\/10.1186\/s12943-020-01209-2 (2020).","journal-title":"Mol. Cancer"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-34785-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-34785-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-34785-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,16]],"date-time":"2023-05-16T06:01:57Z","timestamp":1684216917000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-34785-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,16]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["34785"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-34785-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,16]]},"assertion":[{"value":"23 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7894"}}